Patent · US Active

BCMA chimeric antigen receptors

US11351236B2 · kind B2 · utility

7Cited by
37References
39Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2020
Grant dateJun 7, 2022
Priority date—
Expiry dateOct 23, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.